Surgery and Proton Beam Therapy for Tracheal Synovial Sarcoma.
Ye Cong,Junhong Guo,Xiaogang Liu,Gening Jiang,Weixi Wang
DOI: https://doi.org/10.1016/j.athoracsur.2020.01.058
2020-01-01
Abstract:Synovial sarcoma (SS) is an uncommon malignant tumor associated with poor prognosis, and SS arising from the trachea is even rarer, with only 3 cases reported previously. We present the case of a 19-year-old man for whom imaging studies revealed a mass of soft tissue density in the lower trachea. An en bloc trachea segmental resection and postoperative proton beam therapy were performed. Diagnosis was confirmed by the SS18-SSX gene rearrangement. The patient was alive without tumor recurrence for 18 months. This case report presents tracheal SS successfully treated with surgery and postoperative proton therapy. Synovial sarcoma (SS) is an uncommon malignant tumor associated with poor prognosis, and SS arising from the trachea is even rarer, with only 3 cases reported previously. We present the case of a 19-year-old man for whom imaging studies revealed a mass of soft tissue density in the lower trachea. An en bloc trachea segmental resection and postoperative proton beam therapy were performed. Diagnosis was confirmed by the SS18-SSX gene rearrangement. The patient was alive without tumor recurrence for 18 months. This case report presents tracheal SS successfully treated with surgery and postoperative proton therapy. Synovial sarcoma (SS) is a rare subtype of soft tissue sarcomas with an incidence of 0.12 to 0.18/100,000 people per year,1Corey R.M. Swett K. Ward W.G. Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report.Cancer Med. 2014; 3: 1404-1415Crossref PubMed Scopus (70) Google Scholar,2Fletcher C.D. The evolving classification of soft tissue tumours - an update based on the new 2013 who classification.Histopathology. 2014; 64: 2-11Crossref PubMed Scopus (314) Google Scholar often involving the soft tissue of the extremities. Synovial sarcoma of the trachea is exceptional; only 3 cases were previously reported in the literature.3Reilly G. Johnston G. Obstructing synovial sarcoma in the trachea of a 10 year old boy.Paediatr Anaesth. 2010; 20: 287-288Crossref Scopus (4) Google Scholar, 4Corrales C.E. Berry G. Damrose E.J. Primary cervical tracheal monophasic synovial sarcoma confirmed by SYT-SSX gene rearrangement.J Laryngol Otol. 2011; 125: 651-654Crossref Scopus (5) Google Scholar, 5Sykes A.T. Rokkas C.K. Kajdacsy-Balla A. Haasler G.B. Primary tracheal synovial cell sarcoma: a first case report.J Thorac Cardiovasc Surg. 1997; 114: 678-680Abstract Full Text Full Text PDF PubMed Scopus (6) Google Scholar The patient in the current report had tracheal SS successfully treated with surgery and postoperative proton therapy, and the case was confirmed by molecular analysis. A 19-year-old male college student experienced hemoptysis and progressive dyspnea 2 weeks before admission. The patient had a 2-year history of smoking (10 cigarettes/d). Evaluation included a computed tomography (CT) scan (Figure 1A, B ), which showed a mass of soft tissue density (CT value of 84 Hounsfield units) at the right wall of the mediastinum trachea (3.4 × 2.8 cm), some of which protruded into the trachea lumen. A whole-body positron emission tomography–CT scan with the glucose analog 2-[18F] fluoro-2-deoxy-d-glucose (FDG) demonstrated nodular foci on the right wall of the lower trachea with increased FDG metabolic activity (maximum standardized uptake value = 2.51) (Figure 1C), whereas no abnormal FDG metabolic activity was found in other parts of the body (Figure 1G), indicating the primary origin of the tracheal tumor. The patient underwent bronchoscopy to visualize the extent of the tumor better (Figure 1D, E). Results showed that the right wall of the lower part of the trachea was incompletely blocked by a spherical neoplasm with local necrosis. High-frequency electrosurgical resection of tumor was performed to relieve dyspnea symptoms caused by airway obstruction. The lower edge of the lesion was 1.5 cm above the carina level (Figure 1F). Two days later, the patient underwent en bloc trachea segmental resection through the right posterolateral incision through the fifth intercostal space. A circular neoplasm (2.5 × 3.5 × 2 cm) was seen on the right wall of the trachea near the upper edge of the azygos vein. The mediastinum pleura on the tumor surface was smooth and the tumor invaded into the trachea lumen, with its lower edge only 1.5 cm above the carina. After the trachea was fully separated from the surrounding tissues, a 5-cm trachea segment was resected. The upper and lower edges of the trachea were about 1 cm away from the tumor. No cancer invasion was found in the frozen pathological sections of the surgical margins. The upper and lower segments of the trachea underwent sleeve suture with absorbable string, with the membrane part sutured continuously and the cartilage sutured intermittently in a U-shape. The anastomosis was covered with an intercostal muscle flap. Pathological examination of the resected tissue showed a malignant spindle cell neoplasm composed of abundant uniform cells (Figure 2A). Numerous mitotic images of nucleus could be seen. The subcarina and paratracheal lymph nodes were negative. Further immunohistochemical staining was performed that showed that the spindle cells were negative for α-smooth muscle actin, signal transducer and activator of transcription 6, desmin, cluster of differentiation (CD)99, anaplastic lymphoma kinase, and S100 protein, whereas they were positive for vimentin, B-cell lymphoma 2, CD56, CD34 (vascular positive), cytokeratin (focal positive), and epithelial membrane antigen (focal positive). Fluorescence in situ hybridization demonstrated an SS18-SSX translocation (Figure 2B), which confirmed the diagnosis of SS. The patient recovered uneventfully and was discharged home 10 days after surgery without postoperative complications. The patient was referred to radiation oncology and received proton beam therapy (DT63GyE/18Fx [Dose of Target, 63 Gray Effective/18 Fractions]). Eighteen months after surgery, the patient showed no evidence of recurrence as observed by serial examinations including chest CT (Figure 3A, B ) and bronchoscopy (Figure 3C).Figure 3(A, B) Postoperative chest computed tomography and (C) bronchoscopy images showing no evidence of recurrent disease.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Synovial sarcoma is a rare malignant mesenchymal spindle cell tumor accounting for 5% to 10% of all soft tissue sarcomas.1Corey R.M. Swett K. Ward W.G. Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report.Cancer Med. 2014; 3: 1404-1415Crossref PubMed Scopus (70) Google Scholar,6Sultan I. Rodriguez-Galindo C. Saab R. Yasir S. Casanova M. Ferrari A. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients.Cancer. 2009; 115: 3537-3547Crossref PubMed Scopus (212) Google Scholar It has a specific chromosomal translocation t(X; 18) (p11; q11) resulting from fusion of the SS18 gene on chromosome 18 to exon 5 of the SSX gene, which is seen in more than 90% of SS and results in the formation of SS18-SSX fusion oncogenes.7Thway K. Fisher C. Synovial sarcoma: defining features and diagnostic evolution.Ann Diagn Pathol. 2014; 18: 369-380Crossref PubMed Scopus (160) Google Scholar A comprehensive literature search of PubMed, Ovid MEDLINE, and Ovid Embase was conducted and only 3 cases of primary tracheal SS were found. The first was reported in 1997: a 20-year-old white man with a 3-cm tumor located in the upper trachea. An en bloc trachea segmental resection and traditional radiotherapy were performed and no recurrence was found after 8 months of follow-up.5Sykes A.T. Rokkas C.K. Kajdacsy-Balla A. Haasler G.B. Primary tracheal synovial cell sarcoma: a first case report.J Thorac Cardiovasc Surg. 1997; 114: 678-680Abstract Full Text Full Text PDF PubMed Scopus (6) Google Scholar The second case was a 10-year-old white boy with the tumor located in the lower trachea, which was resected under a rigid bronchoscope. The patients recovered well 2 weeks after the operation.3Reilly G. Johnston G. Obstructing synovial sarcoma in the trachea of a 10 year old boy.Paediatr Anaesth. 2010; 20: 287-288Crossref Scopus (4) Google Scholar The third case was a 48-year-old white woman. A 3-cm intratracheal tumor was located in the upper trachea, arising from the right lateral wall. She underwent en bloc trachea segmental resection without radiotherapy or chemotherapy and had no evidence of recurrence at 1 year after surgery.4Corrales C.E. Berry G. Damrose E.J. Primary cervical tracheal monophasic synovial sarcoma confirmed by SYT-SSX gene rearrangement.J Laryngol Otol. 2011; 125: 651-654Crossref Scopus (5) Google Scholar It could be inferred that patients with tracheal SS are young with a male predominance. Optimal treatment should be en bloc tumor resection with radiotherapy. There are 2 types of radiotherapy for tumors: photon beam therapy and particle beam therapy (protons and carbon ions). Particle beam therapy was superior for dose concentration and the cell-killing effect, and its efficacy and safety in soft tissue sarcoma have been reported.8Demizu Y. Jin D. Sulaiman N.S. et al.Particle therapy using protons or carbon ions for unresectable or incompletely resected bone and soft tissue sarcomas of the pelvis.Int J Radiat Oncol Biol Phys. 2017; 98: 367-374Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar The current patient received proton beam therapy instead of photon beam therapy because the tumor was located deep in the tissues. Primary tracheal SS is exceptionally rare with an insidious onset. It may be confirmed by histological examination, immunohistochemical staining, and in situ hybridization. This case of tracheal SS was successfully treated by en bloc tumor resection with adjuvant postoperative proton beam therapy. This may be an optimal treatment option, but further investigation is required.